Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer. [electronic resource]
Producer: 20060307Description: 318-23 p. digitalISSN:- 0090-8258
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Doxorubicin -- administration & dosage
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Organoplatinum Compounds -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Oxaliplatin
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.